AstraZeneca Proposes a Merger With Gilead Sciences
The coronavirus pandemic put a stranglehold on big pharma dealmaking, but it looks like the logjam's about to break. AstraZeneca (NYSE: AZN) has spoken with Gilead Sciences (NASDAQ: GILD) about forming a gigantic biopharmaceutical powerhouse.
People familiar with the matter told Bloomberg that the big British drugmaker informally floated the idea with Gilead in May to gauge interest. No terms have been discussed, but this would be the largest deal the healthcare sector has ever seen.
Image source: Getty Images.
Source Fool.com
